Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Efficient radiosynthesis of a new PSMA ligand: [Al18F]DTPA-CHX-DUPA-Pep

Noeen Malik, Benjamin Baur, Hans Machulla, Sven Reske and Christoph Solbach
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1165;
Noeen Malik
1University Hospital, Ulm, Clinic for Nuclear Medicine, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Baur
1University Hospital, Ulm, Clinic for Nuclear Medicine, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Machulla
1University Hospital, Ulm, Clinic for Nuclear Medicine, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Reske
1University Hospital, Ulm, Clinic for Nuclear Medicine, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Solbach
1University Hospital, Ulm, Clinic for Nuclear Medicine, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1165

Objectives The targeting of prostate specific membrane antigen (PSMA) has become highly attractive for molecular imaging of prostate cancer with PET/CT in the last years. Particularly, clinical application of [68Ga]-labeled PSMA ligands, bearing urea moieties such as DUPA, are of great interest. Instead of a Ge-68/Ga-68 generator, for centers having a cyclotron for [18F]fluoride production, radiofluorination via Al18F2+ appears to be a good alternative. Therefore, DUPA-Pep was coupled to DTPA-CHX-A” which shows higher thermodynamic as well as good in-vivo stability in comparison to NOTA as verified in additional experiments.

Methods Na18F was eluted by 0.9%NaCl after fixing of [18F]fluoride on a Waters Sep Pak QMA-light cartridge and added to each vial containing 20µL of peptide (1, 10, 25, 50, 100, or 200µg in 0.05M NaOAc, pH: 5.5) and 3µL of 0.01M AlCl3.6H2O solution in 0.05M NaOAc. Experiments were carried out between 60-100°C for 1, 5, 10, 20, and 30min. Analyses were performed by radio-TLC (75%MeCN, Rf: 0.78).Additionally, the product fractions after gradient elution by radio-HPLC (C18, 250x4.6mm, A:MeCN/0.1%TFA, B:water/0.1%TFA, 2mL/min; Rt: 9.7min, Rt Al18F2+: 1.6min) were collected for γ-counter analyses, too. For final formulation, [Al18F]DTPA-CHX-A”-DUPA-Pep was eluted after solid phase extraction from Waters Sep Pak C18-light cartridge with 1mL of EtOH.

Results With 200µg to 100µg at 100°C, maximum RCYs (≥90%) were obtained at 5min with decrease to 79% at 30min. Using 50µg at 100°C , RCY of 89±1% was obtained at 5min and 87±1.4% after 1min at 60°C. However, with 1µg at 60°C, RCY was 13±1% (30min, radio-HPLC). The stability studies in serum at 37°C showed no free Al18F2+ after 6h. The quality control showed ≥98% radiochemical purity.

Conclusions [Al18F]DTPA-CHX-A”-DUPA-Pep was efficiently and fast prepared by using Al18F2+ in RCYs of 90% providing complete serum stability with the advantage of the longer half-life compared to the [68Ga]-labeled compound.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Efficient radiosynthesis of a new PSMA ligand: [Al18F]DTPA-CHX-DUPA-Pep
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Efficient radiosynthesis of a new PSMA ligand: [Al18F]DTPA-CHX-DUPA-Pep
Noeen Malik, Benjamin Baur, Hans Machulla, Sven Reske, Christoph Solbach
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1165;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Efficient radiosynthesis of a new PSMA ligand: [Al18F]DTPA-CHX-DUPA-Pep
Noeen Malik, Benjamin Baur, Hans Machulla, Sven Reske, Christoph Solbach
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1165;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Assessment of α4β2 nicotinic acetylcholine receptor (nAChR) availability and neuronal response to rewarding food-cues in human obesity using simultaneous PET-MRI
  • Bridging brain structural/functional connectivity and tau load in PSP: A [18F]PI-2620 PET/MRI study
  • MACROPA highly stable chelator of Radium-223 and functionalization attempts for targeted treatment of cancer
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Special MTA: Novel Radiochemistry and Chelation Posters

  • Synthesis of N-(4-diethylamino)benzyl-4-[11C]methoxy-N-(p-tolyl)benzenesulfonamide as a new PET radioligand for imaging of CB2 receptor
  • First clinical application of a non-cyclic peptidomimetic theranostic
  • Nucleophilic fluorination on electron-rich aromatic rings from non-aromatic precursors: F-18 labeling study and interference from target water
Show more Special MTA: Novel Radiochemistry and Chelation Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire